EUVIMEDOpdag EUVIMED
Open access

Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation Velocity

Varshini Babu iD, Jane A Little, Claudia R Morris, Roberto Machado, Simon Gibbs, Gregory J Kato, Victor R Gordeuk, Mark T Gladwin, Yingze Zhang, Seyed Mehdi Nouraie

PROTEOMICS – Clinical Applications · 2025

DOI: 10.1002/prca.70019 ↗

At a glance

Journal article in PROTEOMICS – Clinical Applications, 2025. Written by Varshini Babu and 9 co-authors. Institution: Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Major MEDLINE topics: Anemia, Sickle Cell, Tricuspid Valve Insufficiency, Proteomics. 14 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Pulmonary hypertension (PH) is a chronic complication of sickle cell disease (SCD) with limited known biomarkers, beyond increases in plasma brain natriuretic peptide levels. Experimental Design We conducted a proof‐of‐concept study to identify serum protein biomarkers that were differentially expressed in SCD patients with elevated tricuspid regurgitation velocity (TRV—a noninvasive marker of PH).

Results

We found 41 out of 92 target proteins that were significantly different between the nonelevated (TRV ≤ 2.6 m/s; N = 35) and highly elevated TRV group (TRV ≥ 2.9 m/s; N = 35, p < 0.05). Six of them passed a Bonferroni correction ( p value < 0.0005), including T‐cell surface glycoprotein, lymphotactin, SLAM family member 7, galectin‐9, TNF‐related apoptosis‐inducing ligand receptor 2, and tumor necrosis factor receptor superfamily member 11A. We observed up to a 1.2‐fold increase in the high TRV group for these six proteins. These six proteins had a strong positive correlation with serum NT‐proBNP levels (a positive control marker elevated in PH [ r ≥ 0.44]). Additionally, these markers correlated with other clinical parameters of PH in SCD.

Conclusion

Circulatory protein markers of the immune response are increased in SCD patients with elevated TRV as compared to those without elevated TRV. Summary This study demonstrates that the circulatory protein markers of the immune response are increased in SCD patients with elevated TRV compared to those without elevated TRV. These biomarkers may be important tools for risk‐stratifying patients with SCD or targets for therapeutic intervention.

Subjects

MeSH terms (MEDLINE)

Anemia, Sickle CellTricuspid Valve InsufficiencyProteomicsHumansFemaleMaleAdultBiomarkersMiddle AgedHypertension, PulmonaryYoung AdultNatriuretic Peptide, Brain

Author keywords

biomarkershematological diseasepulmonary hypertensionsickle cell diseasestatistical analysis

Substances

BiomarkersNatriuretic Peptide, Brain

Authors and institutions

  • Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Medicine, Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Department of Medicine, Indiana University, Indianapolis, Indiana, USA.
  • Imperial College London, London, UK.

ORCID profiles: Varshini Babu

Funding

  • NHLBI NIH HHS

Cite

APA

Babu, V., Little, J. A., Morris, C. R., Machado, R., Gibbs, S., Kato, G. J., Gordeuk, V. R., Gladwin, M. T., Zhang, Y., & Nouraie, S. M. (2025). Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation Velocity. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.70019

Vancouver

Babu V, Little JA, Morris CR, Machado R, Gibbs S, Kato GJ, et al. Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation Velocity. PROTEOMICS – Clinical Applications. 2025. doi:10.1002/prca.70019

BibTeX
@article{Babu2025,
  author = {Babu, Varshini and Little, Jane A and Morris, Claudia R and Machado, Roberto and Gibbs, Simon and Kato, Gregory J and Gordeuk, Victor R and Gladwin, Mark T and Zhang, Yingze and Nouraie, Seyed Mehdi},
  title = {Targeted Proteomic Analysis of Sickle Cell Disease Patients With Elevated Tricuspid Regurgitation Velocity},
  journal = {PROTEOMICS – Clinical Applications},
  year = {2025},
  doi = {10.1002/prca.70019}
}
Start for free →